Hawkins, Inc. (NASDAQ:HWKN – Get Free Report) CFO Jeffrey Oldenkamp acquired 1,290 shares of the stock in a transaction dated Thursday, August 27th. The shares were bought at an average cost of $119.00 per share, with a total value of $153,510.00. Following the completion of the transaction, the chief financial officer owned 104,223 shares of the company’s stock, valued at approximately $12,402,537. This represents a 1.25% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
Hawkins Trading Up 3.6%
Shares of NASDAQ:HWKN opened at $124.58 on Wednesday. The company has a current ratio of 2.27, a quick ratio of 1.54 and a debt-to-equity ratio of 0.45. The company’s 50 day moving average is $134.48 and its two-hundred day moving average is $146.90. The company has a market cap of $2.60 billion, a PE ratio of 32.27, a P/E/G ratio of 2.45 and a beta of 0.78. Hawkins, Inc. has a 52 week low of $116.04 and a 52 week high of $186.15.
Hawkins (NASDAQ:HWKN – Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The specialty chemicals company reported $1.35 earnings per share for the quarter, missing analysts’ consensus estimates of $1.39 by ($0.04). The business had revenue of $315.68 million during the quarter, compared to analyst estimates of $313.42 million. Hawkins had a net margin of 7.29% and a return on equity of 15.42%. Equities analysts predict that Hawkins, Inc. will post 4.1 earnings per share for the current fiscal year.
Hawkins Dividend Announcement
Wall Street Analysts Forecast Growth
Several brokerages recently issued reports on HWKN. Weiss Ratings cut Hawkins from a “hold (c+)” rating to a “hold (c)” rating in a research report on Thursday, August 27th. Barclays set a $142.00 target price on shares of Hawkins and gave the stock an “equal weight” rating in a research note on Friday, July 31st. Zacks Research downgraded shares of Hawkins from a “hold” rating to a “strong sell” rating in a report on Tuesday, August 4th. Finally, BWS Financial reiterated a “buy” rating and set a $200.00 price target on shares of Hawkins in a research note on Monday, August 3rd. One research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Hawkins has an average rating of “Hold” and a consensus target price of $171.00.
Get Our Latest Report on Hawkins
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of HWKN. Kestra Advisory Services LLC acquired a new stake in Hawkins in the fourth quarter valued at $29,000. MBM Wealth Consultants LLC acquired a new position in shares of Hawkins during the 1st quarter worth $33,000. Northwestern Mutual Wealth Management Co. purchased a new position in shares of Hawkins in the 2nd quarter valued at about $37,000. Simplex Trading LLC lifted its stake in shares of Hawkins by 246.0% in the fourth quarter. Simplex Trading LLC now owns 346 shares of the specialty chemicals company’s stock valued at $49,000 after purchasing an additional 246 shares during the period. Finally, Advisory Services Network LLC acquired a new stake in shares of Hawkins in the third quarter valued at about $79,000. Institutional investors and hedge funds own 69.71% of the company’s stock.
About Hawkins
Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.
Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.
See Also
- Five stocks we like better than Hawkins
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.
